Dialysis company DaVita tapped Javier Rodriguez to take over as CEO on June 1, replacing longtime chief Kent Thiry, who is retiring from the post after 20 years.
Since joining DaVita in 1998, Rodriguez has served as CEO of DaVita Kidney Care—the company's largest business segment—since 2014. The other segment, DaVita Medical Group, is in the process of being sold to UnitedHealth Group's Optum subsidiary for $4.3 billion.
Thiry has been CEO and chairman of DaVita since 1999. He is also the CEO of the medical group. Thiry will transition to executive chairman of the board of directors when Rodriguez takes over.
Net income attributable to Denver-based DaVita was $159 million on revenue of $11.4 billion in 2018.